ARTICLE | Management Tracks
Promotions at Twist, as COO steps down
Plus CFO retires at Travere and updates from Nucleome, Maxwell, VectivBio and more
April 22, 2022 12:04 AM UTC
Synthetic DNA company Twist Bioscience Corp. (NASDAQ:TWST) promoted Tracey Mullen to SVP of operations from VP, general manager, and Nimisha Srivastava to SVP of R&D from VP of engineering. Additionally, COO Patrick Weiss will transition to a strategic adviser role for personal reasons. A search for his successor has begun.
Laura Clague will retire as CFO of Travere Therapeutics Inc. (NASDAQ:TVTX) in August 2022, after which she will serve as an adviser into 2023 to facilitate the transition. Chris Cline, SVP of investor relations and corporate communications, will succeed Clague after her retirement. The rare disease company expects to submit an NDA for sparsentan to treat IgA nephropathy this quarter. ...